These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36930101)

  • 41. The impact of COVID-19 on routine pediatric vaccination delivery in Brazil.
    Moura C; Truche P; Sousa Salgado L; Meireles T; Santana V; Buda A; Bentes A; Botelho F; Mooney D
    Vaccine; 2022 Apr; 40(15):2292-2298. PubMed ID: 35287987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SARS-COV-2 Vaccines: What Indicators are Associated with the Worldwide Distribution of the First Doses.
    Sobral MFF; Bezerra de Oliveira BR; Gomes da Penha Sobral AI; Monteiro Marinho ML; Duarte GB; de Souza Melo A
    Inquiry; 2021; 58():469580211060184. PubMed ID: 34823403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anatomy of the first six months of COVID-19 vaccination campaign in Italy.
    Gozzi N; Chinazzi M; Davis JT; Mu K; Pastore Y Piontti A; Ajelli M; Perra N; Vespignani A
    PLoS Comput Biol; 2022 May; 18(5):e1010146. PubMed ID: 35613248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The notable global heterogeneity in the distribution of COVID-19 cases and the association with pre-existing parasitic diseases.
    Chang T; Jung BK; Chai JY; Cho SI
    PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010826. PubMed ID: 36215332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rotavirus infections and vaccines: burden of illness and potential impact of vaccination.
    Grimwood K; Lambert SB; Milne RJ
    Paediatr Drugs; 2010 Aug; 12(4):235-56. PubMed ID: 20593908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Testing the Club Convergence Dynamics of the COVID-19 Vaccination Rates Across the OECD Countries.
    Xu W; Lau CKM; Zhang D; Oke O
    Front Public Health; 2022; 10():872561. PubMed ID: 35602128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Application of distributed lag models and spatial analysis for comparing the performance of the COVID-19 control decisions in European countries.
    Hadianfar A; Rastaghi S; Tabesh H; Saki A
    Sci Rep; 2023 Oct; 13(1):17466. PubMed ID: 37838819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relative deprivation, inequality and the Covid-19 pandemic.
    Chakrabarty D; Bhatia B; Jayasinghe M; Low D
    Soc Sci Med; 2023 May; 324():115858. PubMed ID: 36989836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disparities in access to COVID-19 vaccine in Verona, Italy: a cohort study using local health immunization data.
    Benoni R; Sartorello A; Moretti F; Marchiori F; Accordini L; Postiglione C; Coffele V; Tardivo S
    Front Public Health; 2023; 11():1167414. PubMed ID: 37397767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is There Any Relationship Between the Number of COVID-19 Tests by Country with the Income Inequality of Countries? A Comparison with Income Inequality Metrics.
    Çıtak N; Pekçolaklar A
    Turk Thorac J; 2022 Mar; 23(2):137-144. PubMed ID: 35404246
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
    Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
    PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urban monitoring, evaluation and application of COVID-19 listed vaccine effectiveness: a health code blockchain study.
    Wang T; Li C; Li H; Li Z
    BMJ Open; 2022 Jul; 12(7):e057281. PubMed ID: 35831042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early trends of socio-economic and health indicators influencing case fatality rate of COVID-19 pandemic.
    Asfahan S; Shahul A; Chawla G; Dutt N; Niwas R; Gupta N
    Monaldi Arch Chest Dis; 2020 Jul; 90(3):. PubMed ID: 32696629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of association between vaccination rates and excess mortality in Cyprus during the COVID-19 pandemic.
    Lytras T; Athanasiadou M; Demetriou A; Stylianou D; Heraclides A; Kalakouta O
    Vaccine; 2023 May; 41(18):2941-2946. PubMed ID: 37012116
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Countries with high deaths due to flu and tuberculosis demonstrate lower COVID-19 mortality: roles of vaccinations.
    Pathak S; Jolly MK; Nandi D
    Hum Vaccin Immunother; 2021 Sep; 17(9):2851-2862. PubMed ID: 33857399
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccine hesitancy among communities in ten countries in Asia, Africa, and South America during the COVID-19 pandemic.
    Harapan H; Anwar S; Yufika A; Sharun K; Gachabayov M; Fahriani M; Husnah M; Raad R; Abdalla RY; Adam RY; Khiri NM; Ismaeil MI; Ismail AY; Kacem W; Dahman NB; Teyeb Z; Aloui K; Hafsi M; Ferjani M; Deeb DA; Emad D; Abbas KS; Monib FA; Sami FS; Subramaniam R; Panchawagh S; Anandu S; Haque MA; Ferreto LE; Briones MF; Morales RB; Díaz SA; Aburto JT; Rojas JE; Balogun EO; Enitan SS; Yomi AR; Durosinmi A; Ezigbo ED; Adejumo EN; Babadi E; Kakemam E; Malik NI; Ullah I; Rosiello DF; Emran TB; Wendt GW; Arab-Zozani M; Wagner AL; Mudatsir M
    Pathog Glob Health; 2022 Jun; 116(4):236-243. PubMed ID: 34928187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of good governance, economic growth and universal health coverage on COVID-19 infection and case fatality rates in Africa.
    Gebremichael B; Hailu A; Letebo M; Berhanesilassie E; Shumetie A; Biadgilign S
    Health Res Policy Syst; 2022 Nov; 20(1):130. PubMed ID: 36437476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. COVID-19 DEATHS AND VACCINATION IN NIGERIA: AN APPRAISAL.
    Okoro EO; Ikoba NA; Giwa AO; Okoro BE; Akpila AS; Salihu MO
    West Afr J Med; 2023 Dec; 40(12 Suppl 1):S40. PubMed ID: 38071481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaccination Rate and Incidence of COVID-19 and Case Fatality Rate (CFR): A Correlational Study Using Data From 2019 to 2021.
    Muttappallymyalil J; Chandrasekhar Nair S; Changerath R; Sreejith A; Manda S; Sreedharan J
    Cureus; 2022 Aug; 14(8):e28210. PubMed ID: 36158447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.